Search

Schematic sketch clarified the stepwise synthesis process of N,S-CDs.

In this work, the binding mechanism between donepezil (DNP) and bovine serum albumin (BSA) was established using several techniques, including fluorimetry, UV- spectrophotometry, synchronous fluorimetry (SF), fourier transform infrared (FTIR), fluorescence resonance energy transfer (FRET) besides molecular docking study. The fluorescence quenching mechanism of DNP-BSA binding was a combined dynamic and static quenching. The thermodynamic parameters, binding forces, binding constant, and the number of binding sites were determined using a different range of temperature settings. Van't Hoff's equation was used to calculate the reaction parameters, including enthalpy change (ΔHο) and entropy change (ΔSο). The results pointed out that the DNP-BSA binding was endothermic. It was shown that the stability of the drug-protein system was predominantly due to the intermolecular hydrophobic forces. Additionally, the site probing method revealed that subdomain IIA (Site I) is where DNP and BSA's binding occurs. This was validated using a molecular docking study with the most stable DNP configuration. This study might help to understand DNP's pharmacokinetics profile and toxicity as well as provides crucial information for its safe use and avoiding its toxicity.

Silver nanoparticles (AgNPs) were found to significantly quench the fluorescence of bambuterol hydrochloride (BAM) and its active metabolite terbutaline sulfate (TER). The intrinsic fluorescence intensity of each of BAM (at 264/292 nm) and TER (at 276/306 nm) decreased by the gradual addition of AgNPs. Quenching of the steady state fluorescence of BAM and TER probably resulted from the energy transfer to the photo-excited state of AgNPs. The estimated Stern–Volmer quenching constant at several temperature settings proved that the quenching mechanism of the two drugs was dynamic quenching in case of BAM while it was static quenching in case of TER. The number of binding sites, binding constants, and corresponding thermodynamic parameters depending on the interaction system were estimated at 293, 313, and 333 °K and the results obtained were interpreted.

Validated LC-MS method for the direct quantitative analysis of galantamine (acetylcholinesterase inhibitor) was developed in rat cerebrospinal fluid and brain homogenate besides rat plasma, utilizing structurally close nalbuphine as an internal standard. After a simple protein precipitation step, samples are separated on 2-μm C18 column kept at 40 °C, using isocratic flow of 80% methanol in pH 9.5 ammonium formate buffer, and retention times were about 1.8 and 2.9 min for galantamine and nalbuphine, respectively. Mass detection with electrospray ionization (ESI) and positive polarity was able to detect 0.2 ng mL-1 galantamine using single ion monitoring mode (SIM) at m/z 288 for galantamine and m/z 358 for nalbuphine. The method showed linearity within the range of 0.5 - 300 ng mL-1. The proposed method was validated according to FDA guidelines. Trueness and precision showed acceptable values at all quality control levels, and recoveries were within 85.6 - 114.3% in all matrices at all runs and with relative standard deviations within 0.2 - 12.4%. The method was used to study in vivo brain uptake and pharmacokinetics of galantamine from brain homogenate and plasma samples following the administration of nasal galantamine-bound chitosan nanoparticles compared to oral and nasal galantamine solutions, in scopolamine-induced Alzheimer's disease rat model.

A novel spectrophotometric method is described, including multivariate regression/model updating, for the analysis of a quaternary mixture of clopidogrel, atorvastatin, aspirin, and its degradation product salicylic acid. The multivariate algorithms adopted are partial least squares with and without using a "Genetic Algorithm" for selecting variables. Upon updating both models, they could be effectively applied to determine the studied drugs in their pharmaceutical formulations. Similarly, clopidogrel and aspirin in their combined pharmaceutical preparations could be readily determined. Moreover, the proposed method could be extended to the determination of spiked salicylic acid as a minor component in aspirin raw material and dosage forms. The accuracy and precision of the proposed methods were approved through statistical comparison with the reported methods.

Simple and rapid spectrophotometric methods are described for determination of two mixtures of tamsulosin (TM), as minor component, with either solifenacin (SL) or tolterodine (TL). The proposed methods involve treatment of the absorbance ratio spectra or zero order spectra by derivative or discrete Fourier function. TM and TL mixture could not be resolved by manipulation of their zero order spectra due to the strong overlap between both spectra and only derivative or Fourier function coefficients of ratio spectra could resolve their spectra. TM and SL mixture was fully resolved by the manipulation of both ratio and zero order spectra. The values of the derivative or the Fourier function coefficients of ratio spectra and/or zero order spectra, at either peak or trough points, were correlated to the concentration of each drug in each mixture. Calibration graphs were linear in ranges 2.5-40 and 30-500 μg.mL−1 using derivative ratio and Fourier function ratio, 5-40 and 80–600 μg.mL−1 using direct derivative and 2.5–40 and 30–300 μg.mL−1 using direct Fourier function for TM and SL, respectively. The plots of derivative ratio amplitude and the Fourier function ratio coefficient versus concentration were linear over ranges 2.5–20 and 25–250 μg.mL−1 for TM and TL, respectively. Higher sensitivity as indicated by lower values of detection and quantitation limits were obtained using Fourier convoluted spectra (ratio or zero order) compared to derivative methods. All validation aspects per ICH guidelines are included. The proposed methods were also applied for the studied drugs assay in their tablets and capsules.

Because of the frequent treatment of dairy cows with nitroxynil (NTX), the presence of the later residues in animal tissues and milk has a significant concern. The quantum yield of the reaction product was calculated. A highly sensitive and rapid spectrofluorometric method for determining the anthelmintic drug (NTX) residual amounts is developed. The proposed approach is based on using Zn/HCl to reduce NTX nitro group to an amino group, resulting in a highly fluorescent derivative that was detected at each of λ

Two simple validated and highly selective methods for analysis of paracetamol, codeine, guaifenesin and pseudoephedrine or phenylephrine quaternary mixtures were developed. The first method is a high performance liquid chromatography with diode array detection method where separation was successful using Agilent C18 (150 × 4.6 mm) column, gradient elution of phosphate buffer pH 3, methanol and acetonitrile and diode-array detection at 210 nm. The second method is a HPTLC method followed by densitometric measurement of the spots at 257 nm. Separation was carried out on Merck HPTLC aluminum sheets of silica gel using methylene chloride: methanol: glacial acetic acid: ammonia (17.8: 1.68: 0.4: 0.12, v/v) mobile phase. The methods were applied successfully for analysis of both quaternary mixtures in laboratory-prepared tablets and also validated in regards to linearity, precision, accuracy, sensitivity and stability.

Comorbid conditions of heart and liver disorders added to HCV-induced hepatic steatosis make co-administration of statins, and direct-acting antivirals is common in clinical practice. This study aimed to evaluate the pharmacokinetic interaction of atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir "FDCSL" with rationalization to the underlying mechanism.A randomized, three-phase crossover study that involves 12 healthy volunteers was performed. Participants received a single-dose of atorvastatin 80 mg alone, atorvastatin 80-mg plus tablets containing 400/90 mg FDCSL, or tablets containing 400/90 mg FDCSL alone. Plasma samples were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for atorvastatin, sofosbuvir, ledipasvir, and sofosbuvir metabolite "GS-331007," and their pharmacokinetics parameters were determined.Compared to atorvastatin alone, the administration of FDCSL caused a significant increase in both areas under the concentration-time curve from time zero to infinity (AUCAfter concurrent administration of FDCSL with atorvastatin, the AUC

This study represents simple inexpensive chromatographic determination of ciprofloxacin (CIP) and tinidazole (TIN) simultaneously in human plasma using HPLC-DAD followed by a pharmacokinetic application. C18 column was used as stationary phase with isocratic elution of a mobile phase composed of acetic acid solution (2%) and acetonitrile (85: 15, v/v) and ornidazole as internal standard (IS) with UV detection at 318 nm. The two drugs and the IS were separated at 6.55, 7.91 and 11.07 min for CIP, TIN and IS, respectively, with good selectivity and sensitivity for their analysis in presence of plasma matrix components and the drugs' metabolites. Sample preparation involved only protein precipitation without any complicated extraction procedures decreasing analysis time. For method validation, FDA regulations for analysis in biological fluids were followed. Pharmacokinetic (PK) study on six healthy volunteers was conducted after single oral dose administration of 500 and 600 mg of CIP and TIN, respectively. Dugs' plasma levels were followed for 12 or 72 h post dosing for CIP and TIN, respectively, and different PK data for the two drugs were calculated and they were comparable to the reported values demonstrating successful future application of the presented method in PK, bioequivalence and bioavailability studies.

A sensitive, simple and rapid stability-indicating HPLC method using fluorescence detection was developed for the quantitative determination of the antihistaminic drug cyproheptadine hydrochloride ...

For the past three decades, pharmaceutical research has been mainly converging to novel carrier systems and nanoparticulate colloidal technologies for drug delivery, such as nanoparticles, nanospheres, vesicular systems, liposomes, or nanocapsules to impart novel functions and targeting abilities. Such technologies opened the gate towards more sophisticated and effective multi-acting platform(s) which can offer site-targeting, imaging, and treatment using a single multifunctional system. Unfortunately, such technologies faced major intrinsic hurdles including high cost, low stability profile, short shelf-life, and poor reproducibility across and within production batches leading to harsh bench-to-bedside transformation.Currently, pharmaceutical industry along with academic research is investing heavily in bioconjugate structures as an appealing and advantageous alternative to nanoparticulate delivery systems with all its flexible benefits when it comes to custom design and tailor grafting along with avoiding most of its shortcomings. Bioconjugation is a ubiquitous technique that finds a multitude of applications in different branches of life sciences, including drug and gene delivery applications, biological assays, imaging, and biosensing.Bioconjugation is simple, easy, and generally a one-step drug (active pharmaceutical ingredient) conjugation, using various smart biocompatible, bioreducible, or biodegradable linkers, to targeting agents, PEG layer, or another drug. In this chapter, the different types of bioconjugates, the techniques used throughout the course of their synthesis and characterization, as well as the well-established synthetic approaches used for their formulation are presented. In addition, some exemplary representatives are outlined with greater emphasis on the practical tips and tricks of the most prominent techniques such as click chemistry, carbodiimide coupling, and avidin-biotin system.

Four simple and sensitive spectrophotometric methods were developed for the determination of the sulfhydryl containing drug mesna (MSN). Methods I and II rely on nucleophilic aromatic substitution reactions using two UV tagging reagents namely: 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) for method I and 2,4-dinitrofluorobenzene (DNFB) for method II. Both reactions took place in alkaline buffered medium and the obtained yellowish products were measured at 414 and 332 nm for methods I and II, respectively. Methods III and IV are indirect spectrophotometric methods based on the suppressive effect of MSN on the absorption of two ternary complex systems which are composed of 1,10-phenanthroline, silver and eosin for method III and 1,10-phenanthroline, silver and bromopyrogallol red for method IV. The decrease in absorbance of the ternary complexes was measured at 547 and 635 nm for methods III and IV, respectively. All the experimental parameters affecting these reactions were carefully studied and optimized. The methods were validated as per the ICH guidelines. The methods were applicable in the linearity ranges 4–18 μg/mL for method I, 4–16 μg/mL for method II, 0.25–2.25 μg/mL for method III and 0.25–1.75 μg/mL for method IV. The proposed methods were successfully applied for the analysis of MSN in its commercial ampoules and no interference was encountered from the present excipients as indicated by the satisfactory percentage recoveries. The results obtained were in a good agreement with those obtained from a previously published method of the investigated drug.

Simple, sensitive and specific spectrophotometric (Method I) and spectrofluorimetric (Method II) methods were developed for the determination of three sulfur-containing drugs: mesna (MSN), acetylcysteine (ACT) and timonacic acid (TMN). The methods are based on the suppressive effect of the drugs on the absorbance and the fluorescence intensity of 2′,7′-bis(acetoxymercuri)fluorescein (AMF) in 0.05 M borate buffer. In Method I the decrease in AMF absorbance was measured at 497 nm, while in Method II the fluorescence quenching of the reagent was measured at λem 520 nm (λex 497 nm). All the experimental parameters affecting this reaction were studied and optimized. The selectivity and the stability-indicating aspect of the methods were confirmed and no interference was detected from the oxidation products of the quantified drugs or from other co-administered drugs. Method I was applicable over the concentration ranges 0.5–3, 0.5–2.75 and 0.25–2.75 μg mL−1 for MSN, ACT and TMN, respectively. The reaction sensitivity was enhanced by Method II where the linearity ranges were found to be 0.6–7.2, 0.7–7 and 0.8–10.4 ng mL−1 for MSN, ACT and TMN, respectively. Both methods were applied for the determination of the three drugs in bulk form and in their pharmaceutical preparations without interference from common excipients. The percentage recoveries were satisfactory and they were statistically compared with those obtained from previously reported methods. Moreover, Method II was extended to analyze the drugs in spiked human plasma, by virtue of its high sensitivity.

RC columns often need strengthening to increase their capacity to sustain the applied load. This research investigates the behavior of RC columns strengthened using steel jacket technique. Three variables were considered; shape of main strengthening system (using angles, C-sections and plates), size and number of batten plates. Behavior and failure load of the strengthened columns were experimentally investigated on seven specimens divided into two un-strengthened specimen and five strengthened ones. A finite element model was developed to study the behavior of these columns. The model was verified and tuned using the experimental results. The research demonstrated that the different strengthening schemes have a major impact on the column capacity. The size of the batten plates had significant effect on the failure load for specimens strengthened with angles, whereas the number of batten plates was more effective for specimens strengthened with C-channels. Then, by using finite element (F.E) package ANSYS 12.0 [1] their behavior was investigated, analyzed and verified. Test result showed a good match between both experimental tests and F.E models.

With the rapid and the fast development of artificial intelligence technology, intelligent tutoring Systems (ITSs) are becoming one of the most important area of research and development. Intelligent tutoring Systems have very good impact for making computer-based instruction more adaptive and interactive. Intelligent tutoring Systems are becoming important aspect of educational systems that makes use of adaptive technologies to bring in aspects of a human-teacher delivering personalized and customized tutoring to a student, into online computer-based learning environments. Early Intervention Program (EIP) is very important to improve and enhance the overall development of children with Tiresome 21 (Down syndrome). Up till now, there is no ITS for Early Intervention for Down syndrome children. In order to help a child and parents in the implementation of Early Intervention Program, a proposed ITS framework has been developed. This ITS can help his/her parents assess and evaluate children's' skills in order to provide effective early intervention services to handicaps children according to their mental age and to evaluate their progress and learn. This paper explore the construction requirements to build ITS for Down syndrome children, and the points that differ the ITS for Down syndrome from the traditional ITSs.

Two novel combination therapies for the treatment of benign prostatic hyperplasia were analyzed using simple and enhanced spectrofluorimetric methods based on derivative and derivative ratio techniques. The two combinations contained tamsulosin hydrochloride (TAM) as a minor component with tolterodine tartrate (TOL) or solifenacin succinate (SOL). The fluorescence of the three drugs under study was measured in methanolic water solution. For the TAM and SOL mixture, successful resolution between both drugs was achieved by derivative manipulation of both ratio and zero-order emission spectra with good linearity in the ranges of 0.75-3.50 and 2.5-15.0 μg ml-1 for TAM and SOL, respectively. Extensive emission spectral overlap was observed for the TAM and TOL mixture. Therefore, only derivative application of the ratio emission spectra resolved such overlap and quantitated TAM and TOL simultaneously in the ranges 0.75-3.50 and 2.5-20.0 μg ml-1 for TAM and TOL, respectively. Optimization of various experimental parameters that affected the fluorescence intensity of the three drugs was performed. Successful application of all proposed methods was achieved for analysis of the two drugs in each combination therapy in their laboratory-prepared mixtures and dosage forms with good accuracy and precision.

A comprehensive review with 337 references for the analysis of some selected 4-quinolone drugs belonging to the first and second generations since 2006 up till now is presented. This group includes nalidixic acid, oxolinic acid, piromidic acid, pipemidic acid and rosoxacin from the first generation and enoxacin, fleroxacin, nadifloxacin, pefloxacin and rufloxacin from the second generation. The review covers most of the methods described for the analysis of these drugs, either per se, in dosage forms, biological fluids, environmental samples, cosmetics, animal tissues and feed-premix samples.

In this paper, a simple and highly sensitive spectrofluorimetric method was developed and validated for the determination of entacapone (ETC). The proposed method is based on forming a highly fluorescent product through the reduction of ETC with Zn/HCl. The produced fluorophore exhibits strong fluorescence at λ

A validated and selective high-performance thin-layer chromatography (HPTLC) method was developed for the analysis of mixures of tamsulosin hydrochloride (TAM) with either tolterodine tartrate (TOL) or solifenacin succinate (SOL) in bulk drug and in combined dosage forms. The proposed method is based on HPTLC separation of the three drugs followed by densitometric measurements of their spots at 224 nm. Separation was carried out on Merck HPTLC aluminum sheets of silica gel 60 F254 using ethyl acetate-methanol-ammonia (6:4:0.05, v/v) as mobile phase. The linear regression analysis data were used for the regression line in the range of 0.1-0.7, 0.4-4 and 1-6 μg band-1 for TAM, TOL and SOL, respectively. The proposed method was validated and successfully applied for the analysis of their pharmaceutical formulations and laboratory-prepared mixtures containing the two bicomponent combinations. The method was validated and showed good performances in terms of linearity, sensitivity, precision, accuracy and stability.

The study represents the first report on the development of spectrophotometric methods for determination of ethamsylate (EST) in the presence of hydroquinone as an impurity and/or acidic degradation product. The proposed methods are based on the reaction of EST through it,s secondary amino group either with 1,2-naphthoquinone-4-sulphonate sodium (NQS) at pH 10.7 or 2,4-dinitrofluorobenzene (DNFB) at pH 9.3 to form orange and yellow colored reaction products peaking at 478 and 387 nm for methods (I) and (II), respectively. The different experimental parameters affecting the development and stability of the reaction products in methods (I) and (II) were carefully studied and optimized. The absorbance-concentration plots were rectilinear over the concentration ranges of 2-30 and 2-14 µg mL−1 for methods (I) and (II), respectively. The lower detection limits were 0.13 and 0.19 µg mL−1 and the lower quantitation limits were 0.44 and 0.63 µg mL−1 for methods (I) and (II), respectively. Both methods were successfully applied to commercial ampoules and tablets.

In search for novel anti-cancer and anti-microbial agents with promising pharmacotoxicological profile, the synthesis of some substituted 4-halofuran-2(5H)-ones (8a–l, 9, 11) and derived halogenated quinoxalin-2(1H)-ones (12a–d) is described. Some of the halogenated furanones were readily oxidized to the corresponding 2-bromo-2-propenoic acids (13a–c) with hydrogen peroxide in alkaline medium. Twenty-two compounds were preliminary tested for their in vitro activity against three bacteria and one fungus and revealed encouraging activity. On the other hand, three compounds were screened as anti-cancer agents using cell line panel protocol and 22 compounds were subjected to cycline-dependent kinases (CDKs) inhibition screening program but were inactive.

Spectrophotometric and spectrofluorimetric methods were developed for the determination of oxamniquine (OXM). Both methods are based on coupling with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) in borate buffer of pH 7.6, and the reaction product was measured at 400 nm (Method I). The same product was measured by spectrofluorimetry at 480 nm upon excitation at 400 nm (Method II). The absorbance and the fluorescence intensity were enhanced by addition of sodium dodecyl sulphate (SDS). The absorbance-concentration plot is rectilinear over the range of 5-25 μg/mL with an LOD of 0.31 μg/mL. The fluorescence-concentration plot is linear over the range of 0.2-1.2 μg/mL with an LOD of 0.03 μg/mL. Both methods were applied to the analysis of capsules, and the results were in good agreement with those obtained using the official method. The method was applied to spiked human plasma; the mean % recovery (n = 5) is 101.05 ± 1.65. A proposal of the reaction pathway is presented.

Sensitive methods were developed for the determination of two sulfhydrylcontaining drugs namely acetylcysteine (I) and captopril (II). The methods were based on reacting the drugs with 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) in the presence of sodium tetraborate in absolute methanol. The yellow colored products obtained were measured spectrophotometrically at 417 and 420 nm for (I) and (II), respectively and by differential pulse polarography at -872 and -1007 mV (vs. Ag/AgCl electrode) for compounds (I) and (II) after getting rid of excess unused reagent by extraction with ether. The different experimental parameters were studied and optimized spectrophotometrically. The proposed methods were validated and applied to the determination of the cited drugs in their pharmaceutical preparations. The results were statistically analyzed and compared to those of a reference HPLC method.

Based on the interfacial adsorptive character of danazol onto the hanging mercury drop electrode (HMDE), a simple and sensitive square-wave adsorptive stripping voltammetric (SW-AdSV) procedure for the electrochemical analysis of this drug in pharmaceutical formulations has been developed and validated. Cyclic and SW-AdSV voltammograms showed a single well-defined irreversible cathodic peak. Various chemical and instrumental parameters affecting the monitored electroanalytical response were investigated and optimized for the danazol determination. Under these optimized conditions the SW-AdSV peak current showed a linear dependence on drug concentration over the range 7.5x10(-8)-3.75x10(-7) mol l-1 (r=0.999) with estimated detection limit (at a S/N ratio of 3) of 5.7x10(-9) mol l-1 (1.78 ng ml-1). A mean recovery of 100.9+/-1.2% and relative standard deviation of 1.07% were achieved. Possible interferences by substances usually present in the pharmaceutical tablets and formulations were also evaluated. The proposed electrochemical procedure was successfully applied for the determination of danazol in pharmaceutical capsules (Danol 100 mg) with mean recoveries of 100.48+/-0.87%. Results of the developed SW-AdSV method were comparable with those obtained by reported analytical procedures.

A sensitive differential pulse anodic stripping voltammetric method is described for the determination of alendronate sodium, desferrioxamine mesylate and lisinopril. The procedure is based on the formation of labile drug � /copper(II) complex when shaking with copper(II) phosphate suspension. The voltammetric peaks, which correspond to the reduction of the copper(II) moiety of the formed complexes are obtained at � /153, � /74 and � /111 mV, respectively. The different experimental parameters have been carefully studied. The method has been fully validated. The limit of detection was as low as 8.6 ng ml � 1 . The method has been applied successfully for the determination of the drugs in plasma and in their pharmaceutical preparations. The obtained results were compared statistically with those obtained from a published method, in case of AS, or the official USP methods, for the other two drugs. # 2003 Elsevier Science B.V. All rights reserved.

A highly sensitive, simple and rapid spectrofluorimetric method was developed for the determination of Amlexanox (AMX) in its bioadhesive buccal tablets. The proposed method is based on measuring the native fluorescence of the methanolic solution of AMX at 400 nm after excitation at 242 nm in 0.2 M borate buffer (pH 10) and 0.5% w/v sodium dodecyl sulfate (SDS) solution. The interaction of AMX with SDS was studied, and the enhanced fluorescence intensity was exploited to develop an assay method for the determination of AMX. The relative fluorescence intensity-concentration plot was rectilinear over the range 5.0-80.0 ng/mL, with a lower detection limit of 0.57 ng/mL and a lower quantification limit of 1.74 ng/mL. The proposed method was successfully applied to the analysis of AMX in its commercial tablets. Moreover, content uniformity testing was conducted by applying official USP guidelines. Statistical evaluation and comparison of the data obtained using the proposed and comparison methods revealed good accuracy and precision for the proposed method.

Spectrophotometric and spectrofluorimetric procedures for the quantitative determination of four penicillins [Amoxycillin (AMX), Bacampicillin (BAC), Piperacillin (PPN) and Sultamcillin (SULT)] and ten cephalosporins [Cefadroxil (CDL), Cefamandole nafate (MAN), Cefuroxime axetil or sodium (CFX), Cefaclor (CFCR), Ceftazidime (CZD), Ceftizoxime (CTIZ), Ceftriaxone (CTRX), Cefoperazone (CPZ), Cefixime (CXIM) and Cefpodoxime proxetil (CFPD)] are described. Both methods are based on the acidic oxidation of the antibiotics with cerium (IV) at elevated temperature. The effect of the reagent concentration, volume of the acid,and the heating temperature were studied to optimize the reaction conditions. Each antibiotic was determined by either measuring the absorbance difference at 317 nm or the cerous inherent fluorescence at 256 and 356 nm for excitation and emission wavelengths, respectively. The two procedures have been successfully applied to the assay of these antibiotics in their pharmaceutical dosa...

Two simple, rapid specific methods were developed for the determination of heptaminol and mexiletine and their dosage forms. The methods are based on the reaction of either heptaminol or mexiletine with acetylacetone-formaldehyde reagent to give a yellow chromophore measurable spectrophotometrically at 344 or 338 nm or flurometrically at 480 nm for heptaminol and mexiletine, respectively. The color was stable for at least 1/2 h. Beer's law was valid within a concentration range of 15–30 and 8–20 μg ml−1 spectrophotometrically and 0.2–0.8 and 0.4–1.0 μg ml−1 fluorometrically for heptaminol and mexiletine, respectively.

A spectrophotometric procedure is described for the determination of three phenolic sympathomimetic drugs: etilefrine hydrochloride, prenalterol hydrochloride and ritodrine hydrochloride. The method involves the use of 2,6-dichloro- and 2,6-dibromoquinone chlorimides as chromogenic reagents. The phenolic drugs produce a blue color, peaking from 610 to 630 nm. The colors produced obey Beer's law and are suitable for the quantitative determination of the named compounds. The molar ratios of the reactions were established and a proposal for the reaction pathway is given. The procedures described were applied successfully to the determination of the compounds in their dosage forms. The results showed that the proposed procedures compared favourably with the reference methods and satisfactory sensitivity, accuracy and precision (SD < 0.1 μg ml−1) were noted. Detection limits are typically 0.2–0.4 μg ml−1. Other advantages of the procedures are their simplicity and speed.

A highly sensitive, simple and rapid spectrofluorimetric method was developed for the determination of amisulpride (AMS) and bumidazone (BUM) in tablet form. The proposed method is based on measuring the native fluorescence of the studied drugs in methanol at 360 and 344 nm after excitation at 276 and 232 nm for AMS and BUM, respectively. The fluorescence-concentration plots were rectilinear over the ranges of 5.0-60.0 ng/mL for AMS and 0.5-5.0 µg/mL for BUM. The lower detection limits were 0.70 ng/mL and 0.06 µg/mL, and the lower quantification limits were 2.0 ng/mL and 0.18 µg/mL for AMS and BUM, respectively. The method was successfully applied for the analysis of AMS and BUM in commercial tablets. Statistical evaluation and comparison of the data obtained using the proposed and comparison methods revealed good accuracy and precision for the proposed method.

Capillary electropherosis (CE) has been proved to be an important alternative to high-performance liquid chromatography (HPLC) in pharmaceutical analysis. However, when it comes to the analysis of compounds, e.g. impurities or metabolites, of very different polarity and water solubility CE and the related techniques come to its limits. This is demonstrated for the antipsychotic drug quetiapine and its impurities. A nonaqueous capillary electrophoresis (NACE) method was developed using a background electrolyte (BGE) composed of ammonium acetate dissolved in a mixture of acetonitrile and methanol including acetic acid to protonate the substances. The NACE method gave an excellent separation of all components. Since the conductivity of the BGE used in the NACE method is quite low and problems with current occurred, an additional aqueous capillary zone electrophoresis (CZE) method was developed for quetiapine and the two water soluble derivatives, using phosphate buffer as BGE. The method was validated with regard to repeatability and limit of detection.

A simple and rapid liquid chromatographic method was developed and validated for the determination of triclabendazole with high accuracy and precision within 6 min. Good chromatographic separation was achieved using a CLC Shim-pack C8 (250 × 4.6 mm, 5 µm particle size) using the mobile phase containing a mixture of 0.02 m phosphate buffer and methanol with a ratio of (20 : 80 v/v) at pH 4.0 was pumped at a flow rate of 1.2 mL/min with fluorescence detection for the first time at 338 nm after excitation at 298 nm. Losartan potassium was used as an internal standard. The method showed good linearity in the ranges of 0.05-2.0 µg/mL with limits of detection and quantification of 14.1 and 42.6 ng/mL, respectively. The suggested method was successfully applied for the analysis of triclabendazole in tablets. The high sensitivity of the method enabled the determination of the studied drug in spiked human plasma with mean percentage of recoveries of 99.79 ± 5.09. Statistical evaluation of the data was performed according to ICH Guidelines.